Ординатура / Офтальмология / Английские материалы / Retinal Degeneration Disease_Hollyfield, Anderson, LaVail_1999
.pdf374 |
B.B. THOMAS ET AL. |
trigger this global remodeling. The fetal retinal sheet transplants as a natural replacement for lost photoreceptors may provide the most suitable mechanical support to prevent retinal collapse.
7. FUTURE DIRECTIONS
Fetal retinal sheet transplantation has been shown to have a rescue and restoration effect on visual function in various rodent models with retinal degeneration. Clinical studies indicate that fetal retinal transplants with its RPE can survive without apparent rejection and show improvement in visual acuity in some patients. Additional work is in progress attempting to confirm the reproducibility of these results and enhance the magnitude of the effect. Current and future studies are aiming at improving the interconnections between the transplant and the host retina. Elimination of the inner limiting membrane on the surface of the donor retina that can act as a barrier might lead to improvements in the connectivity between transplant and host. Connectivity could be also improved using appropriate factors that promote neurogenesis and reduce glial scars and trauma.
8. ACKNOWLEDGEMENTS
Supported by Foundation Fighting Blindness, Foundation for Retinal Research, Fletcher Jones Foundation, NIH EY03040 and Private Funds, and an NEI travel grant to BT. For space reasons, only some of the people involved in the studies discussed in this chapter can be mentioned. We thank Zhenhai Chen, Xiaoji Xu, Lilibeth Lanceta, and Betty Nunn for technical assistance. Guanting Qiu (Doheny Eye Institute, Los Angeles, CA); Shinichi Arai (Niigata University, Niigata, Japan); Botir T. Sagdullaev (Washington University, St. Louis); Norman D. Radtke, Heywood M. Petry, Maureen A. McCall, Peng Yang (University of Louisville); Gustaw Woch (Hershey Medical School, Hershey, PA); and Sherry L. Ball (Cleveland University, Cleveland, OH) contributed to the work presented in this paper. We thank Matthew M. LaVail, UCSF, for the founder breeding pairs of transgenic S334ter rats, and Eric Sandgren, University of Wisconsin, for founder breeders of transgenic hPAP rats.
Robert Aramant and Magdalene Seiler have a proprietary interest in the implantation instrument and procedure.
9. REFERENCES
Arai, S., Thomas, B. B., Seiler, M. J., Aramant, R. B., Qiu, G., Mui, C., De Juan, E. and Sadda, S. R., 2004. Restoration of visual responses following transplantation of intact retinal sheets in rd mice. Exp Eye Res, 79:331341
Aramant, R. B. and Seiler, M. J., 2002. Retinal transplantation–advantages of intact fetal sheets. Prog Retin Eye Res, 21:57-73
Aramant, R. B. and Seiler, M. J., 2004. Progress in retinal sheet transplantation. Prog Retin Eye Res, 23:475-494 Aramant, R. B., Seiler, M. J. and Ball, S. L., 1999. Successful cotransplantation of intact sheets of fetal retina with
retinal pigment epithelium. Invest Ophthalmol Vis Sci, 40:1557-1564
Ball, S. L. and Petry, H. M., 2000. Noninvasive assessment of retinal function in rats using multifocal electroretinography. Invest Ophthalmol Vis Sci, 41:610-617
52. RETINAL TRANSPLANTATION – A TREATMENT |
375 |
Boulton, M., Rozanowska, M. and Rozanowski, B., 2001. Retinal photodamage. J Photochem Photobiol B, 64: 144-161
Bowes, C., Li, T., Danciger, M., Baxter, L. C., Applebury, M. L. and Farber, D. B., 1990. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature, 347:677-680 Coffey, P. J., Girman, S., Wang, S. M., Hetherington, L., Keegan, D. J., Adamson, P., Greenwood, J. and Lund, R. D., 2002. Long-term preservation of cortically dependent visual function in RCS rats by transplantation.
Nat Neurosci, 5:53-56
D’Cruz, P. M., Yasumura, D., Weir, J., Matthes, M. T., Abderrahim, H., LaVail, M. M. and Vollrath, D., 2000. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet, 9: 645-651
del Cerro, M., DiLoreto, D., Jr., Cox, C., Lazar, E. S., Grover, D. A. and del Cerro, C., 1995. Neither intraocular grafts of retinal cell homogenates nor live non-retinal neurons produce behavioral recovery in rats with light-damaged retinas. Cell Transplant, 4:133-139
Delyfer, M. N., Leveillard, T., Mohand-Said, S., Hicks, D., Picaud, S. and Sahel, J. A., 2004. Inherited retinal degenerations: therapeutic prospects. Biol Cell, 96:261-269
Fauser, S., Luberichs, J. and Schuttauf, F., 2002. Genetic animal models for retinal degeneration. Surv Ophthalmol, 47:357-367
Girman, S. V., Lu, B. and Lund, R. D., 2003a. Light Adaptation Study in RCS Rats, Untreated and with Subretinal Graft of Human RPE Cells. ARVO abstract:program #482
Girman, S. V., Sauve, Y. and Lund, R. D., 1999. Receptive field properties of single neurons in rat primary visual cortex. J Neurophysiol, 82:301-311
Girman, S. V., Wang, S. and Lund, R. D., 2003b. Cortical visual functions can be preserved by subretinal RPE cell grafting in RCS rats. Vision Res, 43:1817-1827
Herreros de Tejada, P., Green, D. G. and Munoz Tedo, C., 1992. Visual thresholds in albino and pigmented rats.
Vis Neurosci, 9:409-414
Hetherington, L., Benn, M., Coffey, P. J. and Lund, R. D., 2000. Sensory capacity of the royal college of surgeons rat. Invest Ophthalmol Vis Sci, 41:3979-3983
Humayun, M. S., Prince, M., de Juan, E., Jr., Barron, Y., Moskowitz, M., Klock, I. B. and Milam, A. H., 1999. Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa. Invest Ophthalmol Vis Sci, 40:143-148
Humphrey, M. F., Chu, Y., Mann, K. and Rakoczy, P., 1997. Retinal GFAP and bFGF expression after multiple argon laser photocoagulation injuries assessed by both immunoreactivity and mRNA levels. Exp Eye Res, 64:361-369
Jiang, L. Q. and Hamasaki, D., 1994. Corneal electroretinographic function rescued by normal retinal pigment epithelial grafts in retinal degenerative Royal College of Surgeons rats. Invest Ophthalmol Vis Sci, 35: 4300-4309
Jones, B. W., Watt, C. B., Frederick, J. M., Baehr, W., Chen, C. K., Levine, E. M., Milam, A. H., Lavail, M. M. and Marc, R. E., 2003. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol, 464: 1-16
Kwan, A. S., Wang, S. and Lund, R. D., 1999. Photoreceptor layer reconstruction in a rodent model of retinal degeneration. Exp Neurol, 159:21-33
Lee, D., Geller, S., Walsh, N., Valter, K., Yasumura, D., Matthes, M., LaVail, M. and Stone, J., 2003. Photoreceptor degeneration in Pro23His and S334ter transgenic rats. Adv Exp Med Biol, 533:297-302
Little, C. W., Cox, C., Wyatt, J., del Cerro, C. and del Cerro, M., 1998. Correlates of photoreceptor rescue by transplantation of human fetal RPE in the RCS rat. Exp Neurol, 149:151-160
Liu, C., Li, Y., Peng, M., Laties, A. M. and Wen, R., 1999. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation s334ter during photoreceptor degeneration. J Neurosci, 19:4778-4785
Lund, R. D., Kwan, A. S., Keegan, D. J., Sauve, Y., Coffey, P. J. and Lawrence, J. M., 2001. Cell transplantation as a treatment for retinal disease. Prog Retin Eye Res, 20:415-449
Lund, R. D., Ono, S. J., Keegan, D. J. and Lawrence, J. M., 2003. Retinal transplantation: progress and problems in clinical application. J Leukoc Biol, 74:151-160
Marc, R. E. and Jones, B. W., 2003. Retinal remodeling in inherited photoreceptor degenerations. Mol Neurobiol, 28:139-147
Marc, R. E., Jones, B. W., Watt, C. B. and Strettoi, E., 2003. Neural remodeling in retinal degeneration. Prog Retin Eye Res, 22:607-655
Nusinowitz, S., Ridder, W. H., 3rd and Heckenlively, J. R., 1999. Rod multifocal electroretinograms in mice. Invest Ophthalmol Vis Sci, 40:2848-2858
376 B.B. THOMAS ET AL.
Pittler, S. J. and Baehr, W., 1991. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A, 88:8322-8326
Precht, W. and Cazin, L., 1979. Functional deficits in the optokinetic system of albino rats. Exp Brain Res, 37: 183-186
Prusky, G. T., West, P. W. and Douglas, R. M., 2000. Behavioral assessment of visual acuity in mice and rats. Vision Res, 40:2201-2209
Radtke, N. D., Aramant, R. B., Seiler, M. J., Petry, H. M. and Pidwell, D., 2004. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol, 122:1159-1165
Radtke, N. D., Seiler, M. J., Aramant, R. B., Petry, H. M. and Pidwell, D. J., 2002. Transplantation of intact sheets of fetal neural retina with its retinal pigment epithelium in retinitis pigmentosa patients. Am J Ophthalmol, 133:544-550
Sagdullaev, B. T., Aramant, R. B., Seiler, M. J., Woch, G. and McCall, M. A., 2003. Retinal transplantation-induced recovery of retinotectal visual function in a rodent model of retinitis pigmentosa. Invest Ophthalmol Vis Sci, 44:1686-1695
Santos, A., Humayun, M. S., de Juan, E., Jr., Greenburg, R. J., Marsh, M. J., Klock, I. B. and Milam, A. H., 1997. Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol, 115: 511-515
Sauve, Y., Girman, S. V., Wang, S., Lawrence, J. M. and Lund, R. D., 2001. Progressive visual sensitivity loss in the Royal College of Surgeons rat: perimetric study in the superior colliculus. Neuroscience, 103:51-63
Seiler, M. J. and Aramant, R. B., 1998. Intact sheets of fetal retina transplanted to restore damaged rat retinas.
Invest Ophthalmol Vis Sci, 39:2121-2131
Seiler, M. J., Aramant, R. B. and Ball, S. L., 1999. Photoreceptor function of retinal transplants implicated by lightdark shift of S-antigen and rod transducin. Vision Res, 39:2589-2596
Seiler, M. J., Liu, O. L., Cooper, N. G., Callahan, T. L., Petry, H. M. and Aramant, R. B., 2000. Selective photoreceptor damage in albino rats using continuous blue light. A protocol useful for retinal degeneration and transplantation research. Graefes Arch Clin Exp Ophthalmol, 238:599-607
Seiler, M. J., Sagdullaev, B. T., Woch, G., Thomas, B. B. and Aramant, R. B., in press. Transsynaptic virus tracing from host brain to subretinal transplants. Eur J Neurosci
Siminoff, R., Schwassmann, H. O. and Kruger, L., 1966. An electrophysiological study of the visual projection to the superior colliculus of the rat. J Comp Neurol, 127:435-444
Steinberg, R. H., Matthes, M. T., Yasumura, D., Lau-Villacorta, C., Nishikawa, S., Cao, W., Flannery, J. G., Naash, M., Chen, J. and LaVail, M. M., 1997. Slowing by survival factors of inherited retinal degeneration in transgenic rats with mutant opsin genes. ARVO abstract:S226
Thomas, B. B., Seiler, M. J., Sadda, S. R. and Aramant, R. B., 2004a. Superior colliculus responses to light – preserved by transplantation in a slow degeneration rat model. Exp Eye Res, 79:29-39
Thomas, B. B., Seiler, M. J., Sadda, S. R., Coffey, P. J. and Aramant, R. B., 2004b. Optokinetic test to evaluate visual acuity of each eye independently. J Neurosci Methods, 138:7-13
Wen, R., Song, Y., Cheng, T., Matthes, M. T., Yasumura, D., LaVail, M. M. and Steinberg, R. H., 1995. Injuryinduced upregulation of bFGF and CNTF mRNAS in the rat retina. J Neurosci, 15:7377-7385
Wilson, J. H. and Wensel, T. G., 2003. The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol Neurobiol, 28:149-158
Woch, G., Aramant, R. B., Seiler, M. J., Sagdullaev, B. T. and McCall, M. A., 2001. Retinal transplants restore visually evoked responses in rats with photoreceptor degeneration. Invest Ophthalmol Vis Sci, 42:1669-1676 Yates, J. R. and Moore, A. T., 2000. Genetic susceptibility to age related macular degeneration. J Med Genet, 37:
83-87
CHAPTER 53
MICROARRAY ANALYSIS REVEALS RETINAL STEM CELL CHARACTERISTICS OF THE ADULT HUMAN EYE
For contributed volumes
Brigitte Angénieux1, Lydia Michaut2, Daniel F. Schorderet3, Francis L. Munier1, Walter Gehring2, and Yvan Arsenijevic1,4
1. INTRODUCTION
In western countries, retinitis pigmentosa (RP) affects 1/3,500 individuals and age related macula degeneration (AMD) affects 1% to 3% of the population aged over 60. In vitro generation of retinal cells is thus a promising tool to screen protective drugs and to provide an unlimited cell source for transplantation. However, one main limitation is the amount of cells available. Stem cells, that can generate unlimited quantity of cells, could overcome this hurdle. Indeed, stem cells are defined by three characteristics: the ability to produce a large population of cells (expansion) and the potency, to produce the differentiated cells composing the organ from which the stem cells are originated. They are also able to self-renew indefinitely: for instance haematopoietic stem cells, located in the bone marrow, can expand, divide and generate differentiated cells into the diverse lineages throughout the life, the stem cells conserving its status (Till et al, 1961). Intestinal stem cells also are able to regenerate the intestine all along life (Potten et al, 1975). The other stem cells properties are the ability to produce a large population of cells (expansion) and as well as the differentiated cells composing the organ from which they originated.
Some species, such as the salamanders, can regenerate their retina (Haynes et al, 2004) which is not the case for the human retina. Whether this lack of regeneration is an evolutionary capacity loss, due to a blocking mechanism or a missing signal, is an important question to address. Nevertheless, production of retinal cells can be observed even in species
1 Oculogenetics Unit, Hôpital Ophtalmique Jules Gonin, Lausanne, Switzerland; 2 Dpt of Cell Biology, Biozentrum, Basel, Switzerland; 3 IRO, Institut de Recherche en Ophtalmologie, Sion, Switzerland; 4 Corresponding author: 15 avenue de France, Case Postale 133, CH-1000 Lausanne 7, Switzerland; Tel: +41 21 626 8260; Fax: +41 21 626 8888; yvan.arsenijevic@ophtal.vd.ch.
377
378 |
B. ANGÉNIEUX ET AL. |
where no regeneration occurs. The eye of some fishes and amphibians continues growing during adulthood due to the persistent activity of retinal stem cells (RSCs). In fishes, the RSCs are located in the ciliary margin zone (CMZ) at the periphery of the retina, at the proximity of the iris. Although the adult mammalian eye does not grow during adult life, Tropepe et al (2000) have shown that the adult mouse eye contains retinal stem cells in the homologous zone (termed the ciliary margin zone), in the pigmented epithelium and not in the neuroretina. We demonstrated that the adult human eye also contains retinal stem cells in the same region (i.e. the pars plicata and the pars plana, Coles et al, 2004). These RSCs meet the criteria of stem cells i.e. they can differentiate in vitro into all retinal cells, expand and self-renew. Here, we further characterize the human adult retinal stem cells to investigate whether the adult retinal stem cells share common characteristics with other stem cell populations.
2. ISOLATION OF HUMAN RETINAL STEM CELLS
Stem cells and human retinal progenitors were obtained from organ donors in accordance to their wishes or those of their families. The obtaining and the use of the tissues agreed with the guidelines provided by the Ethical Committee of the Lausanne University School of Medicine. The tissues were processed 10 to 24 hours post-mortem.
The pars plana (figure 53.1: white square) and the pars plicata (figure 53.1: grey square) both gave rise to clonal spheres in vitro in the presence of either EGF, FGF-2 or only with insulin after one week (Figure 53.2A sphere formed after one week in the presence of EGF). Stem cells can be isolated regardless of the age of the donor (from 2 to 82 years old, n = 21, figure 53.2B) suggesting that the stem cell pool is conserved throughout life. We expanded the cells by placing one clonal single sphere into a 24-wells plate in the presence of EGF and 10% FBS. After 3 days, the cells began to spread out of the sphere leading to a monolayer culture in less than one month (Figure 53.2C). The monolayer culture contains highly proliferative progenitor cells that can generate over 300 million cells within one month (Figure 53.2D). During proliferation, 89 +/- 0,02% (n = 3) of the cells express nestin (Figure 53.2E, n = 3), a marker of undifferentiated cells (Tohyama et al., 1992).
3. HUMAN RETINAL STEM CELLS CHARACTERIZATION
To further characterize this cell population, we performed an expression analysis using the Affymetrix® U133 Plus 2.0 GeneChip. We analyzed the global transcriptional expres-
Figure 53.1. Location of the pars plicata (white square) and plana (red square) in the human eye.
53. CHARACTERIZATION OF ADULT HUMAN RETINAL STEM CELLS |
379 |
Figure 53.2. The adult human eye contains highly proliferative undifferentiated cells.
sion of expanded and differentiated hRPCs from two different donors (E and L). During expansion (i.e. in the presence of EGF and 10% FBS), RSCs expressed markers present in neural and other stem cells: as evidenced by immunostaining (Figure 53.2E), nestin was detected at a high expression level during the expansion, validating the microarray approach. We also observed the expression of ABCG2 which is present in hematopoietic stem cells (Zhou et al, 2003), or Bmi1 which is required for hematopoietic stem cell (Park et al, 2003, Lessard et al, 2003) and neural stem cell renewal (Molofsky et al, 2003), or nucleostemin which is necessary for NSC renewal (Tsai and McKay, 2002). The expression of Bmi1 was confirmed by RT-PCR (data not shown). Thus, the highly proliferative cells derived from the adult human eye share common characteristics with other stem cells.
The ability of these cells to differentiate into the different cell types composing the organ from which they have been isolated is one of the stem cell characteristics. Thus, to portray the progeny of the RSCs we also analysed their gene expression profile after differentiation (i.e. after withdrawal of FBS and stimulation by EGF). The cells express genes that have different functions in neurons such as genes coding for the skeleton (Map2, Tau), for the synaptic vesicles proteins (SNAPAP). Moreover specific markers of retinal cells are also expressed as shown by the presence of RPE65 (protein are expressed in retinal pigmented cells), opsin, and peripherin (specific to photoreceptors). In one of the cell line, we also detected by immunostaining, cells that have differentiated into retinal neurons and which expressed specific proteins such as calbindin for horizontal cells (Figure 53.3A), syn-
380 |
|
B. ANGÉNIEUX ET AL. |
A |
B |
C |
calbindin |
syntaxin |
recoverin |
Figure 53.3. The RSCs differentiate into retinal neurons.
taxin for amacrine cells (Figure 53.3B), recoverin for photoreceptor and some bipolar cells (Figure 53.3C) and vimentin for glial cells (data not shown).
4. CONCLUSION
We showed that adult human eye contains cells that can easily be expanded (one cell giving rise to more than 100 billion cells) and share common characteristics with other stem cell populations. Furthermore, after differentiation, those cells expressed markers of several retinal cell types such as pigmented epithelium (RPE65), glia (vimentin) or retinal neurons (opsin, recoverin). The potential of generating retinal neurons in vitro is a promising tool. Indeed the human macula is composed of 200,000 cells which represent only 1/1,000,000 of the total number of cells that we can generate from one RSC. Thus, RSCs could circumvent the problem of the cell number limitation for transplantation studies and could serve to dissect the mechanisms leading to the generation of neurons and their survival.
5. REFERENCES
Coles BL, Angenieux B, Inoue T, Del Rio-Tsonis K, Spence JR, McInnes RR, Arsenijevic Y, van der Kooy: Facile isolation and the characterization of human retinal stem cells. PNAS. 2004, 101(44).
Lessard J, Sauvageau G.: Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423(6937).
Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ.: Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425(6961).
Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF.: Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423(6937).
Potten CS, Hendry JH.: Differential regeneration of intestinal proliferative cells and cryptogenic cells after irradiation, Int J Radiat Biol Relat Stud Phys Chem Med. 1975, 27(5).
Till J, and McCulloch E.: A direct measurement of the radiation sensitivity of normal mouse bone marrow cells., Radiat. Res 1961, 14(213).
Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RD, Trojanowski JQ.: Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 1992, 66(3).
Tsai RY, McKay RD.: A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev., 2002 16(23).
Tropepe V, Coles BL, Chiasson BJ, Horsford DJ, Elia AJ, McInnes RR, van der Kooy D.: Retinal stem cells in the adult mammalian eye. Science 2000, 287(5460).
Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP.: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001, 7(9).
CHAPTER 54
USING STEM CELLS TO REPAIR THE
DEGENERATE RETINA
Stem cells in the context of retinal degenerations
Christine M. Hall1,3, Anthony Kicic2, Chooi-May Lai1,3, and
P. Elizabeth Rakoczy1,3
1. INTRODUCTION
It is conceivable that in the future, stem cells will be used in the treatment of retinal degenerative conditions. They could be transplanted to replace the photoreceptor victims of retinal degeneration or to function as vehicles for the provision of survival or regenerative factors. Their full potential will, most likely, only be realized with thorough investigations of both embryonic and adult stem cells. Studies into the use of stem cells for the treatment of retinal degenerations have primarily involved retinal and neural stem cells. A few laboratories, including our own, have investigated allografts of stem cells from more distant sites like the bone marrow to the retina. Still other groups have investigated the application of embryonic stem cells for treatment of retinal degenerations. In this mini-review we will compare adult versus embryonic stem cells for use in the retina and summarize the recent investigations using stem cells to repair the degenerating retina. Due to space limitations, we are unable to cite all relevant papers so have chosen to focus on key articles that have made significant contributions to this field.
2. STEM CELLS FOR THE TREATMENT OF RETINAL DEGENERATIONS
Stem cells may be the ideal candidates for cell replacement therapy. Stem cells (SC) are highly plastic cells that are capable of becoming different types of cells and retain the
1 Centre for Ophthalmology and Visual Science, The University of Western Australia; 2 Department of Respiratory Medicine, Princess Margaret Hospital for Children; 3 Stem Cell Unit, Department of Molecular Ophthalmology, Lions Eye Institute, Nedlands, 6009, Western Australia, Australia. Corresponding author: P.E. Rakoczy, E-mail: rakoczy@cyllene.uwa.edu.au
381
382 |
C.M. HALL ET AL. |
Table 54.1. Comparison of embryonic vs. adult stem cell characteristics.
Embryonic Stem Cells |
Adult Stem Cells |
Pluripotent |
Multipotent |
Unlimited proliferative capacity |
Limited proliferative capacity |
Ethically complicated |
Ethically valid |
Derived from 2 sources – inner cell mass of |
Derived from many sources – e.g. brain, eye, bone marrow |
blastocyst or gonads of foetus |
|
Less likely to contain DNA abnormalities |
May contain more DNA abnormalities |
Can cause teratomas when transplanted |
Less evidence of teratoma formation when transplanted |
Problem of immune rejection |
Can be derived autologously so less likelihood of immune |
|
rejection |
Can be rapidly expanded in vitro |
Some sites contain very small numbers of stem cells |
|
|
capacity for self-renewal. There are advantages and disadvantages associated with the use of both embryonic (ESC) and adult stem cells (ASC) in cell-based therapeutic strateies to treat degenerative disease and these have been summarised in Table 54.1. It is beyond the scope of this article to comprehensively review these aspects in detail and we therefore refer the reader to several excellent articles and reviews specifically dealing with these topics (Daar et al., 2004; Hochedlinger et al., 2004).
The potential of stem cells in a cell replacement strategy for the treatment of degenerative disease has been recognised from the results of both in vitro and in vivo analyses. In vitro analyses of photoreceptor sheets, retinal explants, primary retinal pigment epithelium (RPE), cultured RPE, and of stem cells themselves have contributed to the belief that stem cells may have a role in the treatment of retinal degenerations. Photoreceptor differentiation has been analyzed by co-culture of stem cells with retinal cells from the embryonic retina (Belliveau et al., 2000), neonatal retina (Ahmad et al., 1999; Ahmad et al., 2000), RPE (Chiou et al., 2005), and stromal cells (Hirano et al., 2003). Other studies inducing the differentiation of marrow stromal cells (MSC) into mesodermal, neuroectodermal and endodermal derivatives have also substantiated the ability of stem cells to differentiate into the lineages required for cell replacement in the degenerate retina (Jiang et al., 2002; Woodbury et al., 2002). Perhaps one of the most informative studies demonstrating the potential of stem cells for the treatment of retinal degenerative disease is that of Zhao et al. (2002) where they showed that ESC-derived neural cells express photoreceptor regulatory genes.
Investigations of the viability, integration, and functionality of transplanted retinal tissue have shown promise for possible treatment of retinal degenerations. Transplanted tissue has included fetal (Sagdullaev et al., 2003), and adult sheets or dissociated photoreceptors (Gouras et al., 1991), RPE (Gouras et al., 1989; Wang et al., 2004), full-thickness neuroretina (Ghosh et al., 2004), and microaggregates of neural retina (Gouras and Tanabe, 2003). In a recent study, the activity in the superior colliculus was analysed following transplant of embryonic rat retinal sheets to the retina of a transgenic rat with photoreceptor degeneration where the transplant was shown to improve visual function (Sagdullaev et al., 2003). Using a mouse model, similar results were found to be associated with the rescue of host cones in the transplant recipients (Arai et al., 2004). Whilst such results are promising, there is evidence that rescue of visual function may only be possible if the RPE cells are transplanted prior to the major loss of photoreceptors (Li and Turner, 1991; Castillo
54. STEM CELLS IN THE CONTEXT OF RETINAL DEGENERATIONS |
383 |
et al., 1997). The small number of cells harvested from fetal ocular tissue, and the ethical issues surrounding the use of fetal tissue, present major obstacles to the clinical application of such cell replacement therapy.
3. RECENT INVESTIGATIONS USING STEM CELLS TO REPAIR THE DEGENERATE RETINA
3.1. Transplantation of Embryonic Stem Cells
A number of different laboratories have studied the effects of transplanting ESC into the subretinal space (Schraermeyer et al., 2001; Arnhold et al., 2004; Haruta et al., 2004) and into the vitreous of the eye (Hara et al., 2004; Meyer et al., 2004). Transplantation of undifferentiated murine and primate ESC into the dystrophic RCS rat (Schraermeyer et al., 2001; Haruta et al., 2004) both resulted in establishing a multilayered photoreceptor outer nuclear layer (ONL) compared to a non-existent ONL in the sham-injected animals. Haruta and associates (2004) also presented evidence for a concomitant improvement in visual function. Recently, Meyer et al. (2004) transplanted retinoic acid-induced, ESC-derived, neural precursors intravitreally into five week old rd1 mice. A small proportion of the transplanted cells were able to cross the inner limiting membrane, incorporate into the neural retina and to differentiate into cells expressing neural cell markers whilst resembling neural cell morphology. In the age-matched normal C57BL/6J mouse model, the donor cells remained in the vitreous distant from the retinal surface. This suggests that chemo-attractant or migration factors are present in the degenerate retinas that are not present in the normal model. Arnhold et al. (2004) also differentiated the ESC into neural precursors prior to subretinal transplantation into rhodopsin-knockout mice. The transplanted cells did not appear to disrupt the cellular laminae until 8 weeks post-transplant when teratomas were seen to affect the choroid, retina, and vitreous of host eyes. Hara et al. (2004) also saw teratoma formation after transplantation of ESC intravitreally in mice and this appears to be a major obstacle to the application of ESC in cell replacement therapy.
3.2. Transplantation of Adult-Derived Stem Cells
3.2.1. Retinal-Derived Stem Cells
As with ESC, the subretinal transplantation of retinal stem cells (RSC) into rats with disease or injury has shown the survival, integration and differentiation into cells expressing markers of the neural retina, including photoreceptors (Akagi et al., 2003; Chacko et al., 2003; Klassen et al., 2004a). Injection into normal animal models appears to inhibit the incorporation of such cells into the retina (Chacko et al., 2000; Chacko et al., 2003). Intravitreal injection of RSC into immunocompetent mice (Coles et al., 2004) and rats (Seigel et al., 1998) have shown that RSC survive, migrate from the vitreous and integrate into the neural retina. The characteristics of retinal and neural stem cells (NSC), their developmental roles, molecular mechanisms known to control their specification, and transplantation of NSC into the retina are all described in a comprehensive review by Klassen et al. (2004b).
